Author

Richard G. Lahr

Observed names: R G Lahr, R Lahr, Richard Lahr

Institution: Mayo Clinic

Observed institution: Mayo Clinic

ORCID: 0000-0002-4619-7473

Observed ORCID: 0000-0002-4619-7473

OpenAlex ID: A5018925166

Development of an LC-MS/MS assay with automated sample preparation for phosphatidylethanol (PEth)– Not your typical clinical marker

2023 · Richard G. Lahr, Pragya Sharma, et al. · Journal of Chromatography B · 9

Performance Comparison of Liquid Chromatography and Paper Spray Ionization with Mass Spectrometry for Measuring Kinase Inhibitors in Human Plasma

2025 · Richard G. Lahr, Makenzie Meyer, et al. · ACS Pharmacology & Translational Science · 3

Automated Extraction and Quantification of Immunosuppressants and Anticonvulsants from Dried Blood Spots: Evaluation of Transcend DBSA–TLX-1–MS/MS System

2025 · Pragya Sharma, Alison Lightfoot, et al. · Chromatographia · 1

The challenge that chlorine presented during the development of a benzodiazepine assay

2019 · Richard G. Lahr, Paul J. Jannetto, et al. · Clinical Biochemistry · 1

B-351 Analytical Assessment of Fibronectin and Collagen I Fragment Biomarkers in Hypermobile Ehlers–Danlos Syndrome Using Immunoenrichment and LC–MS/MS

2026 · Yanhong Wu, Zhewei Liang, et al. · Clinical Chemistry

Clinical and genetic characterization of constitutional MLH1 promoter hypermethylation: Implications for Lynch syndrome diagnosis

2026 · Megan F.H. Bishop, Nisha Kanwar, et al. · Genetics in Medicine

B-291 Validation of a Simple Qualitative Immunoassay for 21 Drugs of Abuse in Meconium on a Single Biochip Array

2024 · P Sharma, R G Lahr, et al. · Clinical Chemistry

B-166 Effect of Urine Adulteration on Quantifying both Delta 8- and Delta 9-carboxy tetrahydrocannabinol using a New UPLC-tandem Mass Spectrometry Method

2023 · Y Chai, M Bjergum, et al. · Clinical Chemistry

Works count: 8

Citation count: 14

H-index: 2

I10-index: